Wang, Xj., Rao, Xr., Li, S. et al. Effect of Huanshuai Recipe Oral Liquid (缓衰口服液) on renal dysfunction progression in patients with atherosclerotic renal artery stenosis., Chin. J. Integr. Med. 21, 811–816 (2015). https://doi.org/10.1007/s11655-015-2046-0
Xiu-juan Wang, Xiang-rong Rao, Shen Li, et al. Effect of Huanshuai Recipe Oral Liquid (缓衰口服液) on renal dysfunction progression in patients with atherosclerotic renal artery stenosis[J]. Chinese Journal of Integrative Medicine, 2015,21(11):811-816.
Wang, Xj., Rao, Xr., Li, S. et al. Effect of Huanshuai Recipe Oral Liquid (缓衰口服液) on renal dysfunction progression in patients with atherosclerotic renal artery stenosis., Chin. J. Integr. Med. 21, 811–816 (2015). https://doi.org/10.1007/s11655-015-2046-0DOI:
Xiu-juan Wang, Xiang-rong Rao, Shen Li, et al. Effect of Huanshuai Recipe Oral Liquid (缓衰口服液) on renal dysfunction progression in patients with atherosclerotic renal artery stenosis[J]. Chinese Journal of Integrative Medicine, 2015,21(11):811-816. DOI: 10.1007/s11655-015-2046-0.
Effect of Huanshuai Recipe Oral Liquid (缓衰口服液) on renal dysfunction progression in patients with atherosclerotic renal artery stenosis
摘要
To investigate the effect of Huanshuai Recipe Oral Liquid (缓衰口服液
HSR) on retarding the progression of renal dysfunction in patients with atherosclerotic renal artery stenosis (ARAS). A total of 52 ARAS patients with the Chinese medicine (CM) syndrome of qi deficiency and blood stasis
phlegm and dampness retention were recruited and randomly assigned into the treatment group (36 cases) and the control group (16 cases). Both groups received a basic treatment (high-quality low-protein diet
blood pressure control
lipid-lowering
correcting the acidosis
etc.). In addition
the treatment group received 20 mL HSR and the control group received placebo
3 times a day for 6 months. Renal function (serum creatinine
blood urea nitrogen and uric acid) and blood lipids (cholesterol
triglycerides and low density lipoprotein) were examined monthly. The estimated glomerular fifiltration rate (eGFR) and CM syndrome score were compared between groups. After treatment
compared with the control group
the serum creatinine level
uric acid level and CM syndrome score of the treatment group were signifificantly decreased (P<0.05 or P<0.01)
and the eGFR in the treatment group were significantly increased (P<0.05). HSR can effectively improve the renal function and clinical symptoms of ARAS patients.
Abstract
To investigate the effect of Huanshuai Recipe Oral Liquid (缓衰口服液
HSR) on retarding the progression of renal dysfunction in patients with atherosclerotic renal artery stenosis (ARAS). A total of 52 ARAS patients with the Chinese medicine (CM) syndrome of qi deficiency and blood stasis
phlegm and dampness retention were recruited and randomly assigned into the treatment group (36 cases) and the control group (16 cases). Both groups received a basic treatment (high-quality low-protein diet
blood pressure control
lipid-lowering
correcting the acidosis
etc.). In addition
the treatment group received 20 mL HSR and the control group received placebo
3 times a day for 6 months. Renal function (serum creatinine
blood urea nitrogen and uric acid) and blood lipids (cholesterol
triglycerides and low density lipoprotein) were examined monthly. The estimated glomerular fifiltration rate (eGFR) and CM syndrome score were compared between groups. After treatment
compared with the control group
the serum creatinine level
uric acid level and CM syndrome score of the treatment group were signifificantly decreased (P<0.05 or P<0.01)
and the eGFR in the treatment group were significantly increased (P<0.05). HSR can effectively improve the renal function and clinical symptoms of ARAS patients.
关键词
atherosclerotic renal artery stenosisHuanshuai Recipe Oral LiquidRenal DysfunctionChinese Medicine
Keywords
atherosclerotic renal artery stenosisHuanshuai Recipe Oral LiquidRenal DysfunctionChinese Medicine
references
Seddon M, Saw J. Atherosclerotic renal artery stenosis: review of pathophysiology, clinical trial evidence, and management strategies. Can J Cardiol 2011;27:468–480.
Wang F, Wang M, Wang HY. Patients with atherosclerotic renal artery stenosis prevalence survey. Chin J Nephrol (Chin) 2005;21:139–142.
Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing endstage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994;24:622–629.
de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosisi in risk groups: a systematic literature review. J Hypertens 2009;27:1333–1340.
Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu JN, Chen SC, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005;68:293–301.
Rao XR, Zhang NN, Li S. Preliminary research of syndrome of traditional Chinese medicine on atherosclerotic renal artery stenosis. Chin J Integr Tradit West Med (Chin) 2010;11:125–127.
Li S, Rao XR, Song JY, Meng LQ, Qu L, Li XM. Effects of Huanshuai Recipe Oral Liquid on restructuring glomerular microvasculature and expression of vascular endothelial growth factor in subtotal nephrectomized rats. Chin J Integr Med 2010;16:239–246.
Li S, Rao XR, Dai XW. The clinical observation of longterm curative efficacy of Huanshuai Recipe Oral Solution in treating 35 patients with chronic renal failure. J Tradit Chin Med (Chin) 2001;42:164–166.
Rundback JH, Sacks D, Kent KC, Cooper C, Jones D, Murphy T, et al. American Heart Association. Guidelines for the reporting of renal artery revascularization in clinical trials. Circulation 2002;106:1572–1585.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-S266.
Zheng XY, ed. Guiding principles for clinical research on new drugs of traditional Chinese medicine (trial). Beijing: China Medical Science Press; 2002:163–168.
Mitch WE, Walser M, Buffington GA, Lemann J Jr. A simple method of estimating progression of chronic renal failure. Lancet 1976;2:1326–1328.
Lerman L, Textor S, Grande J. Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond. Progr Cardiovasc Dis 2009;52:196–203.
The ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:1953-1962.
Sos TA. After ASTRAL and STAR—Whither renal artery stenting? Intervent Med Appl Sci 2010;2:153–158.
Dubel G, Murphy T. The role of percutaneous revascularization for renal artery stenosis. Vasc Med 2008;13:141–156.
Adalakha S, Greco B, Dart R, Shepherd A, Murphy T, Jamerson K, et al. Pressure control in patients with renal artery stenosis, preliminary results of the CORAL clinical trial. Circulation 2010;122:A17234.
Zhang NN, Rao XR. Therapy option for renal artery stenosis: percutaneous revascularization or medical treatment? Chin J Integr Tradit West Nephrol (Chin) 2009;10:261–263.
Li XX, Rao XR. Treatment of atherosclerotic renal artery stenosis. Chin J Inform Tradit Chin Med (Chin) 2009;2:90–91.
Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture
Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients
Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome
Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats
Effects of Jianpi Jiedu Recipe (健脾解毒方) on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer
相关作者
暂无数据
相关机构
Georg-August-Universität Göttingen, Göttingen
The Key Laboratory of Geriatrics, Beijing Hospital and Beijing Institute of Geriatrics’ Ministry of Public Health
Medical Informatics Center, Peking University
Department of Hospital Management, Peking University Health Science Center, Peking University
Neurology Department of Peking University Third Hospital, Peking University